313 related articles for article (PubMed ID: 21398613)
1. Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves' disease.
Mao C; Wang S; Xiao Y; Xu J; Jiang Q; Jin M; Jiang X; Guo H; Ning G; Zhang Y
J Immunol; 2011 Apr; 186(8):4734-43. PubMed ID: 21398613
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
[TBL] [Abstract][Full Text] [Related]
3. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells.
McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B
Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263
[TBL] [Abstract][Full Text] [Related]
4. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
5. Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.
Bossowski A; Moniuszko M; Dąbrowska M; Sawicka B; Rusak M; Jeznach M; Wójtowicz J; Bodzenta-Lukaszyk A; Bossowska A
Autoimmunity; 2013 May; 46(3):222-30. PubMed ID: 23249428
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
7. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells in Graves' disease.
Pan D; Shin YH; Gopalakrishnan G; Hennessey J; De Groot LJ
Clin Endocrinol (Oxf); 2009 Oct; 71(4):587-93. PubMed ID: 19222488
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals.
Maggi L; Santarlasci V; Liotta F; Frosali F; Angeli R; Cosmi L; Maggi E; Romagnani S; Annunziato F
J Allergy Clin Immunol; 2007 Aug; 120(2):429-36. PubMed ID: 17604089
[TBL] [Abstract][Full Text] [Related]
11. CD8+CD122+ T cells, a newly identified regulatory T subset, negatively regulate Graves' hyperthyroidism in a murine model.
Saitoh O; Abiru N; Nakahara M; Nagayama Y
Endocrinology; 2007 Dec; 148(12):6040-6. PubMed ID: 17823258
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves' hyperthyroidism.
Zhou J; Bi M; Fan C; Song X; Yang R; Zhao S; Li L; Li Y; Teng W; Shan Z
Clin Exp Med; 2012 Mar; 12(1):39-46. PubMed ID: 21544672
[TBL] [Abstract][Full Text] [Related]
13. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
14. A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.
Xu G; Mou Z; Jiang H; Cheng L; Shi J; Xu R; Oh Y; Li H
Laryngoscope; 2007 May; 117(5):876-80. PubMed ID: 17473687
[TBL] [Abstract][Full Text] [Related]
15. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
[TBL] [Abstract][Full Text] [Related]
16. Increased frequencies of CD4+ CD25+ FOXP3+ regulatory T cells in human nasal inverted papilloma.
Gu Y; Wang C; Han D; Zhang L
Head Neck; 2011 Jul; 33(7):1005-12. PubMed ID: 21674673
[TBL] [Abstract][Full Text] [Related]
17. CD4+CD25+ naturally occurring regulatory T cells and not lymphopenia play a role in the pathogenesis of iodide-induced autoimmune thyroiditis in NOD-H2h4 mice.
Nagayama Y; Horie I; Saitoh O; Nakahara M; Abiru N
J Autoimmun; 2007; 29(2-3):195-202. PubMed ID: 17826032
[TBL] [Abstract][Full Text] [Related]
18. Increase of circulating CD4+CD25highFoxp3+ regulatory T cells in patients with metastatic renal cell carcinoma during treatment with dendritic cell vaccination and low-dose interleukin-2.
Berntsen A; Brimnes MK; thor Straten P; Svane IM
J Immunother; 2010 May; 33(4):425-34. PubMed ID: 20386464
[TBL] [Abstract][Full Text] [Related]
19. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
[TBL] [Abstract][Full Text] [Related]
20. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.
Chen X; Zhou B; Li M; Deng Q; Wu X; Le X; Wu C; Larmonier N; Zhang W; Zhang H; Wang H; Katsanis E
Clin Immunol; 2007 Apr; 123(1):50-9. PubMed ID: 17234458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
